Since OSE Immunotherapeutics was founded in 2012, it has participated in 9 rounds of funding. In total OSE Immunotherapeutics has raised $80.5M. OSE Immunotherapeutics' last funding round was on Apr 2024 for a total of $9.1M.
OSE Immunotherapeutics has 7 investors, including Bpifrance, European Investment Bank and Nantes Metropole. The latest investment occurred in Apr 2024.
